Open AccessUse of Cholesterol-Lowering Therapy by Elderly Adults After Myocardial Infarction
Author(s) -
John Z. Ayanian,
Mary Beth Landrum,
Barbara J. McNeil
Publication year - 2002
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.162.9.1013
Subject(s) - medicine , myocardial infarction , heart failure , diabetes mellitus , adverse effect , cholesterol , high cholesterol , logistic regression , heart disease , cardiology , endocrinology
Use of cholesterol-lowering drugs reduces mortality and adverse cardiac events among people aged 65 to 75 years with coronary heart disease, but previous studies have shown that most patients have not received this treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom